In a study of hemodialysis patients, hypercalcemia accompanied by high parathyroid hormone levels was associated with nearly 2.6-fold increased odds of intradialytic hypotension. The following article ...

Please provide your email address to receive an email when new articles are posted on . Most adults with hypoparathyroidism no longer need vitamin D or calcium supplementation with palopegteriparatide ...

A parathyroid hormone test measures levels of parathyroid hormone (PTH) in your body. This hormone is produced by small glands in your neck and regulates the level of calcium in your blood. A ...

Leptin a Potential Target to Reduce CVD Risk in CKD-MBD TransCon PTH is an investigational once-daily long-acting prodrug of parathyroid hormone (PTH[1-34]) designed to restore physiologic levels of ...

Panel A shows the clinical characteristics and treatments for all six unrelated patients with autosomal dominant hypocalcemia type 1 (ADH1) who received continuous subcutaneous parathyroid hormone ...

Parathyroid hormone (PTH) is an 84 amino acid that plays a key role in phosphocalcic metabolism. Its measurement is essential to diagnose and treat primary hyperparathyroidism and to evaluate chronic ...

Renal Stone Removal Helps Some Patients With Recurrent UTIs In a study, intact parathyroid hormone levels fell by nearly 10% over 6 months in hemodialysis patients who received intensive treatment for ...

New data suggest that a fall in parathyroid hormone (PTH) 12 months after initiating haemodialysis is associated with cardiovascular death at 12–24 months. The main independent predictor for the fall ...

Parathyroid hormone testing is important to monitor the progress of chronic kidney disease (CKD) patients. This presentation will review the basic biochemistry that regulates the calcium, which will ...

The researchers conducted a systematic review and meta-analysis of 12 case-control studies of patients with NAFLD/NASH and a comparison group without NAFLD/NASH. All studies had data on mean PTH ...

Credit: Getty Images. The phase 3 PaTHway trial included 82 adults with chronic hypoparathyroidism. Positive topline results were announced from a phase 3 trial evaluating the efficacy and safety of ...